What it is
Cognitive Behavioral Therapy for Insomnia (CBT-I) is a structured, evidence-based talk therapy for chronic insomnia. Unlike sleep medications, which temporarily induce sleep, CBT-I targets the behaviors and thought patterns that keep insomnia going. A typical program runs 6 to 8 sessions and includes five core components: sleep restriction (temporarily limiting time in bed to build sleep drive), stimulus control (associating the bed only with sleep), sleep hygiene education, cognitive restructuring (challenging unhelpful beliefs like “I’ll never sleep again”), and relaxation techniques. CBT-I can be delivered in person, by telephone, or through digital programs.
How well it works
Strong evidence for CBT-I in menopausal women comes from the MsFLASH CBT-I Trial (McCurry et al., JAMA Internal Medicine, 2016), a randomized clinical trial of 106 perimenopausal and postmenopausal women with insomnia and hot flashes. After 8 weeks of telephone-based CBT-I, Insomnia Severity Index scores dropped by 9.9 points, compared to 4.7 points in the menopause education control group, a statistically significant difference (P<.001). At 8 weeks, 70% of CBT-I participants had ISI scores in the no-insomnia range, compared to 24% of controls. Improvements were sustained at 24 weeks, with 84% of CBT-I participants in the no-insomnia range versus 43% of controls. A 2025 meta-analysis of 11 RCTs (n=973) confirmed that CBT-I significantly improves sleep quality and reduces insomnia severity in menopausal women, regardless of whether it is delivered face-to-face, by telephone, or online.
The Menopause Society (NAMS 2023) recommends cognitive behavioral therapy as a Level I intervention for vasomotor symptoms (good and consistent scientific evidence) and notes that women with vasomotor symptoms and insomnia benefit from CBT for insomnia, though it does not give CBT-I a separate Level I recommendation for insomnia. The American College of Physicians recommends CBT-I as first-line treatment for chronic insomnia in all adults, ahead of sleep medications.
Side effects and cautions
CBT-I does not involve medication, so it has no drug side effects. The main challenge is temporary daytime sleepiness during the first 1 to 2 weeks, when sleep restriction narrows the time in bed to rebuild sleep drive. This is intentional and resolves as sleep consolidates. CBT-I is not appropriate for people with untreated sleep apnea (which should be addressed first), those in an acute manic or psychotic episode, or people with shift work sleep disorder, which is a circadian rhythm disorder rather than chronic insomnia.
Where to get it
CBT-I is delivered by clinical psychologists, behavioral sleep medicine specialists, and CBT-trained therapists. It is available in person, via telehealth, and through self-guided digital programs. Some insurance plans cover CBT-I when provided by a licensed clinician. Check our provider directory for clinics near you.
